BAYLIE TAYLOR: Open Payments
NPI 1285492769 · SMYRNA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,358 in 186 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $2,147 · 2025 $3,358
Food & beverage: $3,358
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $317 |
| ABBVIE INC. | 26 | $310 |
| Amgen Inc. | 21 | $276 |
| Novartis Pharmaceuticals Corporation | 13 | $245 |
| AstraZeneca Pharmaceuticals LP | 10 | $237 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $222 |
| CeQur Corporation | 1 | $204 |
| Axsome Therapeutics, Inc. | 9 | $190 |
| Lundbeck LLC | 12 | $179 |
| Sumitomo Pharma America, Inc. | 8 | $142 |
Products named: REXULTI, LEQVIO, Kerendia, CeQur Simplicity, Auvelity, Ozempic, EVENITY, GEMTESA.
Industry payments across TN — which companies pay providers there.
